November marked the second time this year that the S&P 500 posted a greater than 10% return. The other month was April, the beginning of the current bull market … 8 months ago … or was that 80 years ago?
Ever since, equity performance has been remarkable: NASDAQ up 58.4%. Russell 3000 up 46.3%. Emerging markets up 44.6%. S&P 500 up 41.8%.
There are about 2,400 mutual funds and ETFs in the US Equity category (aka SubType). Their average 8-month return is nearly 50% and 24 of these funds have more than doubled. The top five are all growth of course:
- Baron Partners Retail (BPTRX, Multi-Cap Growth) – 170.9%
- Morgan Stanley Inception Portfolio I (MSSGX, Small-Cap Growth) – 152.2%
- Zevenbergen Genea Inv (ZVGNX, Multi-Cap Growth) – 149.3%
- Morgan Stanley Discovery Portfolio I (MPEGX, Mid-Cap Growth) – 149.2%
- Renaissance IPO ETF (IPO, Small-Cap Growth) – 142.8%
There are even more extraordinary performers. Four funds are up more than 200% so far in the current bull, including three clean energy ETFs:
- GMO Special Opportunities VI (GSOFX, Alternative Global Macro) – 273.4%
- Invesco WilderHill Clean Energy ETF (PBW, Alternative Energy) – 241.8%
- Invesco Solar ETF (TAN, Alternative Energy) – 233.6%
- First Trust NASDAQ Clean Edge Green Energy Index (QCLN, Alternative Energy) – 215.2%
The fund family ARK (mentioned in the June update) was launched in 2014 by former AllianceBernstein officer Catherine Wood and “focuses solely on disruptive innovation.” It has five funds returning more than 100% during this same period … six, if you count the one it sub-advises:
- ARK Genomic Revolution ETF (ARKG, Health/Biotechnology) – 159.9%
- ARK Next Generation Internet ETF (ARKW, Science & Technology) – 157.3%
- ARK Innovation ETF (ARKK, Science & Technology) – 154.5%
- American Beacon ARK Transformational Innovation Y (ADNYX, Global Science/Technology) – 142.9%
- ARK Fintech Innovation ETF (ARKF, Global Science/Technology) – 127%
- ARK Autonomous Technology & Robotics ETF (ARKQ, Industrials) – 106.3%
New site features this month include: 1) five evaluation periods in MultiSearch: 4, 5, 7, 8, and 11 mo, bringing total to 64, and 2) a significant Portfolio Analysis tool upgrade, as described in this month’s commentary.
As always, if you see anything amiss or have suggestions for improvement, let us know and we will respond soonest.
Please enjoy the latest data and site features.